PATENT CLAIM ANALYSIS

Application Number: 16378361
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "718000"]

Abstract:
The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.

Claim (Index 40):
The method of  claim 32 , wherein the determining step comprises measuring, or having measured, the patient's pulmonary capillary wedge pressure, and concluding that, if the pulmonary capillary wedge pressure is greater than 20mmHg, the patient has pre-existing left ventricular dysfunction.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 100.0
- Lexical Diversity: 1.31034
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12821041', '14454373', '14451057', '12821020', '13651660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.846202792532579
- 35 USC 102 Novelty (BERT): 0.6294151608033898
- Combined Prediction Score: 0.8245240293596601
- Mean Citation Score: 668.4344120000002
- Max Citation Score: 676.1624
- Similarity Product: 522.6063120536803

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test